Goldman Sachs’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-707,039
| Closed | -$32.8M | – | 5087 |
|
|
2023
Q2 | $32.8M | Buy |
707,039
+549,422
| +349% | +$25.5M | 0.01% | 1201 |
|
|
2023
Q1 | $4.52M | Sell |
157,617
-13,390
| -8% | -$384K | ﹤0.01% | 2626 |
|
|
2022
Q4 | $5.34M | Buy |
171,007
+128,646
| +304% | +$4.01M | ﹤0.01% | 2572 |
|
|
2022
Q3 | $859K | Buy |
42,361
+28,211
| +199% | +$572K | ﹤0.01% | 3922 |
|
|
2022
Q2 | $220K | Buy |
14,150
+1,115
| +9% | +$17.3K | ﹤0.01% | 4862 |
|
|
2022
Q1 | $249K | Buy |
+13,035
| New | +$249K | ﹤0.01% | 4980 |
|
|
2021
Q4 | – | Sell |
-39,000
| Closed | -$1.28M | – | 5742 |
|
|
2021
Q3 | $1.28M | Buy |
+39,000
| New | +$1.28M | ﹤0.01% | 3812 |
|